SEACH MEDICAL CANNABIS GROUP SINCE 2008 Trademark

Trademark Overview


On Tuesday, January 2, 2018, a trademark application was filed for SEACH MEDICAL CANNABIS GROUP SINCE 2008 with the United States Patent and Trademark Office. The USPTO has given the SEACH MEDICAL CANNABIS GROUP SINCE 2008 trademark a serial number of 79240483. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, June 17, 2019. This trademark is owned by SEACH INTERNATIONAL LTD. The SEACH MEDICAL CANNABIS GROUP SINCE 2008 trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Acetaminophen; anti-cancer preparations; antiallergic medicines; biological preparations for the treatment of cancer; biological preparations for the treatment of post-traumatic stress disorder; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of a coating for slow release that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety ...

Development services of varieties of cannabis plant and a method for developing improved cannabis varieties; services for developing methods for improving varieties of cannabis plant; development of a method of matching a variety of cannabis to the treatment of specific disease; services for developing methods for growing cannabis plant; development a methods of matching a varieties for a treatment of diseases
seach medical cannabis group since 2008

General Information


Serial Number79240483
Word MarkSEACH MEDICAL CANNABIS GROUP SINCE 2008
Filing DateTuesday, January 2, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, June 17, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAcetaminophen; anti-cancer preparations; antiallergic medicines; biological preparations for the treatment of cancer; biological preparations for the treatment of post-traumatic stress disorder; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of a coating for slow release that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug test kits consist of medical reagents and diagnostic tests for body fluids; flower essences for medical purposes for the treatment of pain; gastrointestinal cleaning agents; glaucoma agents; herb teas for medicinal purposes; herbal extracts for medicinal purposes; drugs and medications to treat and promote the recovery from tendon injury in muscles and sports injuries; medications for the treatment of cancer; medicated preparations for skin treatment; medicinal drinks; medicated hair care preparations; hair growth stimulants for medical purposes; medicinal herbs; medicinal herbs in dried or preserved form; drug infusion for the treatment of pain; medicinal oils; oral medicine in the form of aerosols, drops, capsules, tablets and compressed tablets; medications for the treatment of infectious diseases and for the use of oncology; medicinal preparations for pain relief; medicinal radix glycyrrhizae; medicinal roots; medicinal tea used for the treatment of pain; medicines for the treatment of gastrointestinal diseases; medications for the treatment of gastrointestinal disorders; molecular complex for medicinal, surgical, therapeutic or veterinary purposes; natural remedy preparations for the treatment of gastrointestinal conditions, hormonal and chemical imbalances, and sleep disorders; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; preparation for the relief of pain; preparations for the treatment of asthma; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; processed bee pollen and honey for medicinal or therapeutic purposes; processed cactus for medicinal or therapeutic purposes; propolis for medicinal or therapeutic purposes; radioactive substances for use in nuclear medicine; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; solutions for medical and clinical use in storing and treating cells, blood and blood components; sugar replacement for medicinal or therapeutic purposes; sweets for medicinal purposes; test strips for measuring different blood parameters when using cannabis; transdermal patches featuring botanical substances; veterinary preparations, namely, pain relief medication; all the aforesaid goods include cannabis
Goods and ServicesDevelopment services of varieties of cannabis plant and a method for developing improved cannabis varieties; services for developing methods for improving varieties of cannabis plant; development of a method of matching a variety of cannabis to the treatment of specific disease; services for developing methods for growing cannabis plant; development a methods of matching a varieties for a treatment of diseases
Pseudo MarkSEACH MEDICAL CANNABIS GROUP SINCE TWO THOUSAND EIGHT

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 17, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 17, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEACH INTERNATIONAL LTD
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressIL

Trademark Events


Event DateEvent Description
Friday, July 3, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, June 17, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 17, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 6, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 19, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 19, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, June 17, 2019ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, June 17, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, November 24, 2018REFUSAL PROCESSED BY IB
Monday, November 5, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 5, 2018REFUSAL PROCESSED BY MPU
Saturday, October 20, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 19, 2018NON-FINAL ACTION WRITTEN
Friday, October 12, 2018ASSIGNED TO EXAMINER
Friday, September 21, 2018APPLICATION FILING RECEIPT MAILED
Monday, September 17, 2018ASSIGNED TO EXAMINER
Monday, September 17, 2018ASSIGNED TO EXAMINER
Monday, September 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 13, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB